Chatham Lodging Trust
CLDT NYSE Real Estate Investment Trusts Financials FY2016βFY2025
What Chatham Lodging Trust does
No business description yet.
- Legal name
- Chatham Lodging Trust
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001437749-26-006103
0001476045
Revenue and margins
Chatham Lodging Trust had $295M of revenue in fiscal 2025, down 7.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew β17.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Chatham Lodging Trust returned $26.6M to shareholders in fiscal 2025. The diluted share count rose 2.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Chatham Lodging Trust can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $19.2M | $26.3M | $68.1M | $20.2M | $24.4M |
| Debt incl. finance leases | $545M | $470M | $486M | $407M | $339M |
| Net debt / EBITDA | 14.2x | 4.6x | 4.8x | 4.1x | 3.1x |
| Debt / equity | 0.7x | 0.6x | 0.6x | 0.5x | 0.5x |
| Interest coverage | β0.7x | 1.4x | 1.1x | 1.1x | 1.6x |
| Total assets | $1.4B | $1.3B | $1.3B | $1.3B | $1.2B |
| Total liabilities | $597M | $526M | $540M | $463M | $392M |
| Shareholders' equity | $798M | $795M | $776M | $758M | $741M |
| Net debt (β = net cash) | $526M | $444M | $418M | $387M | $315M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 5 / 8 | 4 / 8 | 2 / 8 | 6 / 8 | 7 / 8 | 5 / 8 | 6 / 8 | 5 / 7 |
| Accruals ratio | β4.3% | β4.2% | β3.9% | β4.7% | β4.0% | β3.4% | β4.5% | β5.5% | β5.4% | β4.0% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $296M | $302M | $324M | $328M | $145M | $204M | $295M | $311M | $317M | $295M |
| Gross profit | $147M | $146M | $154M | $154M | $49.4M | $84.7M | $134M | $136M | $136M | β |
| Operating income | $58.9M | $56.4M | $58.1M | $53.4M | β$41.7M | β$17.2M | $36.5M | $28.6M | $33.2M | $40.9M |
| Interest expense | $28.3M | $27.9M | $26.9M | $28.2M | $28.1M | $24.5M | $26.5M | $27.1M | $30.9M | $25.7M |
| Pretax income | $31.4M | $30.1M | $30.8M | $18.9M | β$77.0M | β$18.8M | $9.9M | $2.5M | $4.0M | $15.3M |
| Income tax | β$0.3M | $0.4M | β$0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | $31.5M | $29.5M | $30.6M | $18.7M | β$76.0M | β$18.4M | $9.8M | $2.6M | $4.2M | $15.1M |
| Net income to common | $31.3M | $29.2M | $30.3M | $18.7M | β$76.0M | β$22.4M | $1.9M | β$5.3M | β$3.8M | $7.1M |
| Diluted EPS | $0.81 | $0.73 | $0.66 | $0.39 | β$1.62 | β$0.46 | $0.04 | β$0.11 | β$0.08 | $0.14 |
| Diluted shares | 0.04B | 0.04B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $87.7M | $86.7M | $86.2M | $86.2M | β$20.0M | $28.8M | $71.5M | $76.4M | $73.8M | $64.1M |
| Depreciation and amortization | $48.8M | $46.3M | $48.2M | $51.5M | $53.9M | $54.2M | $59.4M | $58.3M | $60.7M | $59.7M |
| Stock-based compensation | $3.0M | $3.8M | $4.2M | $4.7M | $4.6M | $4.8M | $5.6M | $6.1M | $6.4M | $6.3M |
| Acquisitions | $0.0M | $138M | $70.0M | $8.2M | $0.0M | $71.3M | $31.0M | $0.0M | $43.7M | β |
| Share buybacks | $0.0M | $0.0M | β | β | β | β | β | $0.0M | $0.0M | $9.0M |
| Dividends paid | $53.0M | $52.6M | $61.6M | $62.7M | $16.2M | $0.3M | $0.1M | $14.2M | $14.4M | $17.6M |
| Dividends and buybacks | $53.0M | $52.6M | $61.6M | $62.7M | $16.2M | $0.3M | $0.1M | $14.2M | $14.4M | $26.6M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $12.1M | $9.3M | $7.2M | $6.6M | $21.1M | $19.2M | $26.3M | $68.1M | $20.2M | $24.4M |
| Total debt | $585M | $540M | $585M | $587M | $610M | $545M | $470M | $486M | $407M | $339M |
| Finance lease liabilities | β | β | β | β | β | β | β | $0.0M | $0.3M | $0.3M |
| Total assets | $1.3B | $1.4B | $1.4B | $1.4B | $1.4B | $1.4B | $1.3B | $1.3B | $1.3B | $1.2B |
| Total liabilities | $621M | $582M | $632M | $664M | $678M | $597M | $526M | $540M | $463M | $392M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $677M | $803M | $797M | $762M | $678M | $798M | $795M | $776M | $758M | $741M |
| Margins | ||||||||||
| Gross margin | 49.7% | 48.4% | 47.4% | 46.9% | 34.1% | 41.5% | 45.5% | 43.6% | 42.9% | β |
| Operating margin | 19.9% | 18.7% | 17.9% | 16.3% | β28.7% | β8.4% | 12.4% | 9.2% | 10.5% | 13.9% |
| EBITDA margin | 36.4% | 34.0% | 32.8% | 31.9% | 8.4% | 18.1% | 32.5% | 27.9% | 29.6% | 34.1% |
| Net margin | 10.6% | 9.8% | 9.5% | 5.7% | β52.5% | β9.0% | 3.3% | 0.8% | 1.3% | 5.1% |
| Returns | ||||||||||
| Return on capital | 4.7% | 4.2% | 4.2% | 4.0% | β2.6% | β1.0% | 2.9% | 2.4% | 2.9% | 3.9% |
| Return on equity | 4.7% | 4.0% | 3.8% | 2.4% | β10.6% | β2.5% | 1.2% | 0.3% | 0.5% | 2.0% |
| Return on assets | 2.4% | 2.2% | 2.2% | 1.3% | β5.4% | β1.3% | 0.7% | 0.2% | 0.3% | 1.2% |
| Return on tangible equity | 4.6% | 3.6% | 3.8% | 2.5% | β11.2% | β2.8% | 0.2% | β0.7% | β0.5% | 1.0% |
| Growth | ||||||||||
| Revenue growth | β | 2.0% | 7.4% | 1.3% | β55.9% | 40.8% | 44.6% | 5.5% | 2.0% | β7.0% |
| Net income growth | β | β6.4% | 3.9% | β39.0% | β506.5% | β | β | β73.0% | 57.6% | 261.3% |
| EPS growth | β | β9.9% | β9.6% | β40.9% | β515.4% | β | β | β375.0% | β | β |
| Share count change | β | 4.2% | 15.3% | 1.7% | β0.1% | 3.0% | 1.5% | β0.4% | 0.1% | 2.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | 5.3x | 5.2x | 5.4x | 5.5x | 48.2x | 14.2x | 4.6x | 4.8x | 4.1x | 3.1x |
| Debt / equity | 0.9x | 0.7x | 0.7x | 0.8x | 0.9x | 0.7x | 0.6x | 0.6x | 0.5x | 0.5x |
| Interest coverage | 2.1x | 2.0x | 2.2x | 1.9x | β1.5x | β0.7x | 1.4x | 1.1x | 1.1x | 1.6x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 1.0% | 1.3% | 1.3% | 1.4% | 3.2% | 2.4% | 1.9% | 2.0% | 2.0% | 2.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 5.0 | 4.0 | 2.0 | 6.0 | 7.0 | 5.0 | 6.0 | 5.0 |
| Accruals ratio | β4.3% | β4.2% | β3.9% | β4.7% | β4.0% | β3.4% | β4.5% | β5.5% | β5.4% | β4.0% |
Source: SEC EDGAR XBRL filings (CIK 0001476045). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.